Metabolic stability was evaluated with male CD-1 mouse and mixed-gender human liver microsomes (XenoTech, Lenexa, KS). Test articles (1 μM) were incubated with pooled liver microsomes (0.5 mg protein/mL) for 0, 5, 10, 20, and 30 min at 37 °C in the presence of NADPH. Aliquots (50 μL) were taken at each sampling time point and extracted with 150 μL ice-cold acetonitrile containing the internal standard (labetalol). Following centrifugation, supernatants were diluted five-fold into 35/65 A/B Mobile Phase and analyzed for the parent compound by LC/MS/MS as described in Supplemental Methods. The metabolic competency of microsomal preparations was established using the control compounds: 7-ethoxycoumarin, propranolol, and verapamil. Values for half-life (t1/2) were determined with microsomes from each species by plotting the ln((compound peak area)/(internal standard peak area)) vs. time.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.